BYRON MATHIS: Open Payments
NPI 1578038337 · EVANS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$496 in 11 payments from 8 companies in 2025. Trend: 2023 $354 · 2024 $1,137 · 2025 $496
Food & beverage: $496
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 2 | $189 |
| Boston Scientific Corporation | 1 | $138 |
| ABBVIE INC. | 2 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 1 | $31 |
| Exact Sciences Corporation | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: DEXCOM G7 GSS (161), WATCHMAN FLX, VRAYLAR, FARXIGA, REXULTI, Dexcom G6 Transmitter, The Cologuard Plus Collection Kit, MOUNJARO.
Industry payments across GA — which companies pay providers there.
